JOURNAL OF THROMBOSIS AND THROMBOLYSIS
Scope & Guideline
Innovating research in cardiology and hematology.
Introduction
Aims and Scopes
- Thromboembolic Disease Research:
The journal emphasizes research on various forms of thromboembolic diseases, including venous thromboembolism (VTE), pulmonary embolism, and arterial thrombosis, investigating their epidemiology, risk factors, and clinical outcomes. - Anticoagulation Therapy:
It publishes studies on the efficacy and safety of anticoagulation therapies, including direct oral anticoagulants (DOACs), vitamin K antagonists, and novel anticoagulants, focusing on their use in different patient populations. - Mechanisms of Coagulation and Thrombosis:
Research exploring the underlying biological mechanisms of coagulation, the role of platelets, and the genetic factors influencing thrombotic events is a core focus, contributing to the understanding of thrombosis at a molecular level. - Clinical Guidelines and Practice:
The journal provides a platform for the dissemination of clinical guidelines and best practices in the management of thromboembolic diseases, integrating evidence-based medicine into clinical practice. - Innovative Diagnostic Approaches:
It highlights advancements in diagnostic methodologies for thromboembolic diseases, including imaging techniques and biomarkers, facilitating early detection and management.
Trending and Emerging
- COVID-19 Related Thrombosis:
A significant increase in studies addressing thrombotic complications associated with COVID-19 has emerged, highlighting the pandemic's impact on thromboembolic disease research and management. - Machine Learning and Predictive Analytics:
There is a growing trend towards utilizing machine learning and predictive analytics in identifying thrombosis risk factors and outcomes, representing a shift towards data-driven approaches in clinical research. - Personalized Anticoagulation Strategies:
Emerging research focuses on individualized anticoagulation therapy, considering genetic, demographic, and clinical variables to optimize treatment outcomes for patients. - Cancer-Associated Thrombosis:
An increasing number of studies are dedicated to understanding the mechanisms and management of thrombosis in cancer patients, reflecting the critical interplay between malignancy and thromboembolic risk. - Longitudinal Studies and Real-World Evidence:
There is a trend towards conducting longitudinal and real-world studies to assess the long-term outcomes of various thromboembolic treatments, emphasizing the importance of practical evidence in clinical decision-making.
Declining or Waning
- Traditional Antithrombotic Therapies:
Research on older antithrombotic agents like unfractionated heparin and warfarin is becoming less common as newer therapies gain prominence, leading to a shift in focus towards novel anticoagulants and their comparative effectiveness. - Generalized Risk Factors for Thrombosis:
While risk factors for thrombosis were once a major focus, there is a noticeable decline in studies addressing generalized risk factors, as researchers are now more focused on specific patient populations and their unique risk profiles. - Non-Pharmacological Interventions:
Research on non-pharmacological interventions for thrombosis prevention, such as lifestyle modifications or physical therapies, is less frequently published, likely overshadowed by pharmacological advancements. - Thrombolysis Techniques:
The frequency of studies on traditional thrombolytic techniques appears to be waning, as interest shifts towards more innovative approaches and technologies in thrombectomy and catheter-directed therapies.
Similar Journals
Hematology-American Society of Hematology Education Program
Navigating the Future of Hematology TogetherHematology-American Society of Hematology Education Program is a premier peer-reviewed journal dedicated to advancing the field of hematology through comprehensive educational content. Published by the American Society of Hematology, this journal plays a crucial role in disseminating knowledge to researchers, clinicians, and students in hematology and related disciplines. With an impressive Q1 status in the field, it ranks among the top journals at the forefront of hematological research, as evidenced by its 60th percentile ranking in Scopus' Medicine - Hematology category. Although it does not offer open access, the journal provides invaluable insights and educational resources from leading experts, focusing on the latest advancements, treatment protocols, and evolving understanding of blood disorders. Covering a wide range of topics, from basic research to clinical applications, this journal is essential for anyone seeking to deepen their expertise and stay informed on the latest developments in hematology. For further engagement, readers can access insightful articles published since 2001, ensuring a rich repository of knowledge for ongoing research and clinical excellence.
Vascular Specialist International
Advancing vascular health through global collaboration.Vascular Specialist International, published by the Korean Society of Vascular Surgery, serves as a pivotal platform in the field of vascular surgery and cardiovascular medicine. With an Open Access policy established since 2014, the journal encourages a broader dissemination of research findings to an international audience, fostering collaboration and innovation among researchers, clinicians, and students alike. The journal, ISSN 2288-7970, is headquartered in South Korea and spans a significant publication back to its inception, focusing on advancing clinical practice and research in vascular health. In the 2023 rankings, it is positioned in quartile Q4 for Cardiology and Cardiovascular Medicine and Q3 for Surgery, reflecting its growing impact within the scientific community. Furthermore, it holds commendable Scopus rankings in both categories, indicating its relevance and contributions to the field. With a mission to enhance vascular surgery practices and improve patient outcomes worldwide, Vascular Specialist International stands as an essential resource for those dedicated to advancing the science and art of vascular healthcare.
PHLEBOLOGIE
Pioneering Discoveries in Vascular Health ManagementPHLEBOLOGIE is an esteemed journal published by GEORG THIEME VERLAG KG, serving as a critical platform for the dissemination of research in the field of Cardiology and Cardiovascular Medicine. Since its inception in 1991, the journal has consistently provided a comprehensive range of articles that explore the complexities of vascular health, offering insights into innovative treatments, diagnostic advancements, and emerging trends. Although currently not available as an Open Access publication, PHLEBOLOGIE maintains an impactful presence in the academic community, evident in its 2023 Scopus ranking as Q3 within its category and a percentile standing of 25%. Residing in Germany, PHLEBOLOGIE aims to bridge the gap between research and practice, appealing to researchers, clinicians, and students alike by fostering a deeper understanding of vascular conditions and their management.
BMC Pulmonary Medicine
Connecting researchers and practitioners for impactful insights.BMC Pulmonary Medicine is a leading open access journal dedicated to the field of pulmonary and respiratory medicine, published by BMC since its inception in 2001. With an ISSN of 1471-2466, this journal plays a pivotal role in advancing knowledge and research dissemination in its field, maintaining a prominent position with a 2023 Scopus ranking of #65 out of 155 journals, placing it within the 58th percentile of the category. Based in the United Kingdom, it operates under a collaborative mission to provide unrestricted access to vital research, contributing to the global understanding of respiratory health issues. The journal is recognized for its commitment to high-quality, peer-reviewed research, as evidenced by its Q2 category designation in Pulmonary and Respiratory Medicine. BMC Pulmonary Medicine aims to foster innovation and scholarship among researchers, professionals, and students, making it an indispensable resource for anyone engaged in pulmonary research and practice. The journal, accessible to everyone, enables the dissemination of impactful research that can influence clinical practice and policy worldwide.
International Journal of Stroke
Fostering Innovation in Neurology for Global ImpactThe International Journal of Stroke, published by SAGE PUBLICATIONS LTD, is a leading peer-reviewed journal dedicated to advancing the field of stroke research and clinical practice. Established with a commitment to disseminating high-quality scholarly articles, this journal has rapidly progressed to achieve a prestigious Q1 ranking in both Neurology and Clinical Neurology categories as of 2023. With a remarkably high Scopus rank of #7 among 192 in Neuroscience and #16 among 400 in Clinical Neurology, it places itself firmly in the top 4% of journals in its field, reflecting its significant impact on the academic and clinical landscape. Although it does not currently offer Open Access options, the journal provides a vital platform for researchers and clinicians alike, focusing on innovative treatments, methodologies, and evolving strategies for stroke prevention and recovery. With a publication scope that spans from 2006 to 2024, the International Journal of Stroke continues to foster knowledge exchange and encourage collaboration, making it an essential resource for anyone involved in neurologic healthcare.
Hamostaseologie
Advancing Hematology: Unraveling the Complexities of HemostasisHamostaseologie is a prominent academic journal dedicated to the field of hematology, published by GEORG THIEME VERLAG KG. With an ISSN of 0720-9355 and an E-ISSN of 2567-5761, this journal has been at the forefront of critical research and advancements since its inception in 1981, and it continues to maintain its relevance in the scientific community with a converged publication until 2024. Ranked in the Q3 quartile in Hematology for 2023, and positioned at #44 out of 137 in the Scopus Medicine Hematology category, it represents a substantial contribution to scholarly discourse. Researchers and professionals alike will find valuable insights within its pages, as it disseminates rigorous studies and reviews that address pertinent issues related to hemostasis and coagulation. While the journal does not currently offer Open Access, readers can access its valuable content through institutional subscriptions, making it an essential resource for students, clinicians, and researchers aiming to deepen their understanding of hematological science.
PLATELETS
Pioneering insights into the world of platelets.PLATELETS is a distinguished journal published by Taylor & Francis Inc that has been at the forefront of research in the fields of hematology and medicine since its inception in 1990. With an ISSN of 0953-7104 and an E-ISSN of 1369-1635, this journal boasts a solid reputation, as reflected by its Q2 ranking in both Hematology and Miscellaneous Medicine categories in 2023. PLATELETS serves as an essential platform for disseminating pioneering research, reviews, and case studies related to platelet biology, thrombosis, hemostasis, and their clinical implications. Although not an open-access publication, it is indexed in reputable databases, ensuring visibility and citation of quality contributions. Researchers, clinicians, and students alike will find valuable insights that may inform their work and enhance their understanding of the crucial role of platelets in health and disease. This journal's commitment to advancing knowledge and fostering innovation makes it a pivotal resource in the academic community.
NEUROLOGIST
Enhancing Clinical Practice with Groundbreaking ResearchNEUROLOGIST, an esteemed journal published by Lippincott Williams & Wilkins, serves as a vital resource in the fields of Neurology and Medicine. With an ISSN of 1074-7931 and an E-ISSN of 2331-2637, this journal has been dedicated to advancing the understanding of neurological disorders since its inception in 1996, with continual contributions through 2024. Achieving a respectable Q3 rank in both Medicine (miscellaneous) and Neurology (clinical), it provides an essential platform for disseminating innovative research and clinical studies. Although it is not an open-access publication, NEUROLOGIST promotes a rich exchange of ideas and findings for researchers, healthcare professionals, and students alike, helping to bridge the gaps in neurological research and practice. The journal is recognized for its commitment to enhancing clinical practice and research methodology, making it a valuable asset for anyone engaged in the dynamic field of neurology.
Thrombosis Journal
Fostering collaboration in thrombotic disorder research.Thrombosis Journal is a pioneering open-access publication offering critical insights into the field of hematology, contributing significantly to the understanding of thrombotic diseases. Published by BMC since its inception in 2003, this journal stands out with its commitment to accessibility and dissemination of research, ensuring that valuable findings are readily available to the global scientific community. With an impressive Q2 ranking in the Hematology category as of 2023, the journal boasts a notable presence in the Scopus rankings, positioned at Rank #73/137 in its field. Researchers, healthcare professionals, and students can benefit from a rich array of articles that encompass clinical studies, reviews, and innovative methodologies, all aimed at advancing knowledge and fostering collaboration in the field. The journal is headquartered in the United Kingdom, and its open-access model has enabled a diversity of perspectives and research innovations to flourish, solidifying Thrombosis Journal as an essential resource for those dedicated to combating thrombotic disorders.
Acta Phlebologica
Exploring the Depths of PhlebologyActa Phlebologica, published by EDIZIONI MINERVA MEDICA, is a pivotal journal dedicated to the field of cardiovascular medicine, specifically focusing on the complexities of venous diseases and phlebology. With an ISSN of 1593-232X and an E-ISSN of 1827-1766, this journal serves as a platform for researchers, clinicians, and students to disseminate their findings and insights relevant to venous health. While it currently holds a Q4 status in the Cardiology and Cardiovascular Medicine category, its emphasis on critical aspects of clinical practice and research aims to improve understanding and management of venous disorders. The journal, which has been in circulation since 2013, operates on a subscription basis, ensuring access to high-quality, peer-reviewed content. As the readership grows, Acta Phlebologica aspires to enrich knowledge within the cardiovascular community, fostering advancements in patient care and innovative research.